HealthcarePanel votes against label expansion for Amarin's VascepaOct. 16, 2013 3:16 PM ETAmarin Corporation plc (AMRN) StockAMRNBy: Colin Lokey, SA News Editor13 Comments Amarin's (NASDAQ:AMRN) Vascepa is dealt a bitter blow as an FDA advisory committee votes 9-2 against expanding the drug's label. Shares remain halted. Recommended For YouAbout AMRN StockSymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield (TTM)Rev Growth (YoY)Prev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgAMRN--Amarin Corporation plcTrending AnalysisTrending News